Profile
The main objectives of Dr. Jayagopal's research are to develop
disease-specific imaging and drug delivery agents, and to identify
molecular targets accessible by these agents for clinical
applications in ophthalmology, oncology, and vascular medicine. The
laboratory primarily utilizes nanotechnology-based approaches to
interface drugs and/or imaging agents with diseased cells and
tissues.
Current projects include:
- Nanoscale engineering of imaging and drug delivery carriers for
improved functional capabilities
- Improved targeting and efficacy of gene therapy strategies
- Development of intracellular targeting strategies for imaging and
drug delivery
- Molecular imaging of the retina using optical imaging agents